The life sciences commercial real estate market has undergone a reset this year but is well positioned to be the comeback kid as capital sources grow more confident and green shoots emerge, according to JLL’s 2023 Life Sciences Industry and Real Estate Perspective.
The report explores the state of the industry and identifies trends — and opportunities — for current and future lab space demand, along with the annual ranking of the top innovation communities. In addition, JLL Research has added two new cluster rankings that reveal the top five markets for both medical technology and biomanufacturing.
Though current industry fundamentals have slowed, demand is well positioned to rebound. The top 20 venture capital firms focused on life sciences are waiting to deploy record amounts of capital. They have raised more than $22 bill